Evaluating outcomes of hepatobiliopancreatic surgery
Results of the Surgical Treatment of Patients From Hepatobiliopancreatic Surgical Unit at the Complejo Hospitalario de Navarra
Fundacion Miguel Servet · NCT04556019
This study looks at the health outcomes and survival rates of patients who have had surgery for liver, bile duct, or pancreas issues to see how well they do after the operation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 15 Years to 90 Years |
| Sex | All |
| Sponsor | Fundacion Miguel Servet (other) |
| Locations | 1 site (Pamplona, Navarre) |
| Trial ID | NCT04556019 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the post-surgical morbidity and mortality outcomes of patients who have undergone surgery by the Hepatobiliopancreatic (HPB) Surgical Unit. It will utilize established international classifications to evaluate these outcomes, as well as survival and disease-free survival rates for patients operated on due to tumoral causes. The study includes both retrospective data from the last 10 years and prospective data from patients who consent to participate from January 2019 onwards.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have undergone or will undergo surgery by the HPB Surgical Unit.
Not a fit: Patients who are not eligible for surgery or who do not wish to participate in the study will not benefit from this research.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the safety and effectiveness of hepatobiliopancreatic surgeries, potentially improving patient outcomes.
How similar studies have performed: Other studies have shown success in evaluating surgical outcomes using similar methodologies, indicating that this approach is well-established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients operated by the HPB Surgical Unit in the last 10 years (retrospective) * All patients being operated by the HPB Surgical Unit from January 2019 onwards who provide inform consent (prospective). Exclusion Criteria: * Patients not eligible for surgery * Patients not interested in taking part in the study
Where this trial is running
Pamplona, Navarre
- Complejo Hospitalario de Navarra — Pamplona, Navarre, Spain (RECRUITING)
Study contacts
- Principal investigator: Francisco Javier Herrera Cabezón, MD — Complejo Hospitalario de Navarra
- Study coordinator: Francisco Javier Herrera Cabezón, MD
- Email: javier.herrera.cabezon@cfnavarra.es
- Phone: 0034 848422187
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pancreas Disease, Liver Diseases, Surgical Procedure, Unspecified, Bile Duct Diseases, Hepatobiliopancreatic surgery